PMOS and Diabetes: How the Name Change for PCOS Can Increase Awareness

In a significant development for women’s health, the condition previously known as Polycystic Ovarian Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) as of May 2026. This nomenclature shift, announced following extensive review and consensus among leading endocrinologists and patient advocacy groups, aims to more accurately represent the multifaceted nature of the disorder, emphasizing its profound impact on hormonal balance and metabolic health. The rebranding moves away from the historical, and now understood to be inaccurate, focus on "cysts" and highlights the increased risk of type 2 diabetes, insulin resistance, obesity, and cardiovascular events associated with the condition.

This change is a pivotal moment for the estimated 10-20% of women globally affected by this complex hormonal disorder. For decades, the term PCOS has been a source of confusion and misattribution, often leading patients to believe their symptoms were solely an ovarian issue. The new designation, PMOS, directly addresses this by foregrounding the endocrine and metabolic dysregulations that are central to the syndrome’s presentation and its serious co-morbidities. Over half of women diagnosed with PMOS develop diabetes by the age of 40, a stark statistic that underscores the urgency for a more comprehensive understanding and approach to its management. The renaming signifies a victory for patient empowerment, offering a more precise vocabulary to discuss a condition that often leaves individuals feeling dismissed or misunderstood when grappling with its wide-ranging symptoms.

The historical roots of the term PCOS trace back to early observations where ovarian "cysts" were mistakenly identified as the primary characteristic of the syndrome. This misinterpretation, dating back nearly a century, persisted despite evolving medical understanding. Modern research has clarified that while ovarian morphology can vary, the presence of "cysts" is not a defining feature of PMOS and is often indicative of other unrelated gynecological conditions. The rebranding thus rectifies a long-standing inaccuracy, aligning the medical terminology with current scientific consensus and clinical observation.

Understanding the Shift: From PCOS to PMOS

The decision to rebrand from PCOS to PMOS was not made lightly. It represents a culmination of years of research highlighting the intricate interplay between hormonal imbalances and metabolic dysfunction. The syndrome is characterized by an excess of androgens (male hormones) and insulin resistance, a combination that triggers a cascade of physiological effects. This metabolic dysregulation is the driving force behind many of the challenging symptoms experienced by affected individuals, including difficulties in weight management and blood glucose control, often irrespective of dietary choices or physical activity levels.

The implications of this name change extend beyond mere terminology. It is anticipated to foster greater awareness among healthcare providers regarding the systemic nature of PMOS and its significant association with metabolic diseases. This includes a heightened focus on screening for and managing related conditions such as hypertension and dyslipidemia, which further contribute to the increased risk of cardiovascular events like heart attack and stroke. Furthermore, the new name aims to improve diagnostic accuracy and ensure that women presenting with symptoms of PMOS who also have diabetes are recognized as experiencing a unified, complex endocrine disorder.

Key Characteristics and Symptoms of PMOS

PMOS is a chronic, lifelong hormonal disorder that affects women of reproductive age. Its presentation is highly variable, but common symptoms include:

• Irregular or Absent Menstrual Periods: This is often one of the first indicators, stemming from hormonal imbalances that disrupt ovulation.
• Weight Gain and Difficulty Losing Weight: A significant number of women with PMOS are overweight or obese, with weight gain often concentrated around the abdomen. Studies indicate that 50-70% of women with PMOS fall into this category.
• Insulin Resistance: This is a hallmark of PMOS, where the body’s cells do not respond effectively to insulin, leading to elevated blood glucose levels. This can manifest as dark, velvety patches of skin (acanthosis nigricans) around the neck, armpits, or groin, skin tags, and intense sugar cravings.
• Hirsutism: The growth of excess dark, coarse hair in a male-like pattern, such as on the face, chest, abdomen, or back, due to elevated androgen levels.
• Acne: Persistent and often severe acne that can affect the face, chest, and back.
• Scalp Hair Thinning: A receding hairline or thinning of hair on the scalp, mirroring male-pattern baldness.
• Fertility Challenges: Ovulatory dysfunction can make it difficult to conceive naturally.
• Mood Swings and Mental Health Concerns: Anxiety and depression are commonly reported alongside PMOS.

The underlying pathophysiology involves a vicious cycle. Elevated androgen levels often drive insulin resistance. In response, the pancreas produces more insulin to try and regulate blood sugar. This surge in insulin, in turn, signals the ovaries to produce even more androgens, exacerbating the hormonal imbalance and perpetuating the cycle of metabolic dysfunction and androgen excess.

The Intertwined Relationship Between PMOS and Diabetes

The connection between PMOS and type 2 diabetes is profound and well-established. As noted, over half of women with PMOS develop diabetes by age 40. This elevated risk is directly linked to the persistent insulin resistance that characterizes the syndrome. When insulin resistance becomes severe, the pancreas can no longer produce enough insulin to compensate, leading to chronic hyperglycemia and the eventual diagnosis of type 2 diabetes.

This interconnectedness means that many of the treatment strategies for PMOS and diabetes overlap. Medications like GLP-1 receptor agonists and metformin, commonly used to manage type 2 diabetes by improving insulin sensitivity and regulating blood glucose, are also highly effective in addressing key metabolic aspects of PMOS.

However, the broader spectrum of PMOS symptoms necessitates a more comprehensive therapeutic approach. For issues like hirsutism, acne, scalp hair thinning, mood disturbances, and irregular menstrual cycles, additional interventions such as hormonal birth control or anti-androgen medications may be required. A coordinated treatment plan that addresses both PMOS and diabetes concurrently is crucial for optimizing patient outcomes and achieving overall health improvement by targeting the root causes of these interconnected conditions.

Navigating the PMOS-Diabetes Connection with Healthcare Providers

The high misdiagnosis and undiagnosed rate of PMOS, estimated at 70%, underscores the importance of informed patient-provider communication. Women experiencing symptoms suggestive of PMOS, especially those with a diabetes diagnosis or risk factors, are encouraged to proactively discuss the potential connection with their healthcare team.

1. Articulating the Hormonal Link: Patients should clearly articulate how their physical symptoms, such as weight fluctuations, acne, hair changes, or mood swings, might be linked to their hormonal health and how these symptoms impact their overall well-being, even while managing diabetes. Drawing a direct parallel between existing diabetes care and these endocrine-related issues can help providers understand the holistic picture.

2. Advocating for Comprehensive Androgen Testing: A standard diabetes workup typically does not include reproductive hormone assessments. To properly evaluate for PMOS, it is essential for healthcare providers to order specific androgen testing. This, along with other endocrine hormone levels, helps in confirming a PMOS diagnosis and ruling out other hormonal disorders. Patients should feel empowered to request these specific tests. It is vital that providers are well-versed in the latest International evidence-based guidelines for PCOS assessment and management, which emphasize excluding other endocrine conditions. If a provider lacks familiarity, seeking a PMOS/PCOS specialist is recommended.

3. Optimizing Integrated Medication Plans: If a dual diagnosis of PMOS and diabetes is made, the existing diabetes management plan may require adjustments. This integration aims to simultaneously address hormonal imbalances and metabolic dysregulation, leading to more effective and holistic treatment. For example, medications that improve insulin sensitivity can also help reduce androgen production, creating a synergistic effect.

For individuals unsure if they exhibit PMOS symptoms, self-assessment quizzes are available online as a preliminary step. However, a definitive diagnosis requires professional medical evaluation, including blood work and a clinical assessment.

Lifestyle Interventions: A Dual Approach

Beyond medical management, lifestyle modifications play a critical role in managing both PMOS and diabetes, reducing the risk of complications, and improving quality of life.

1. Mastering "Carbohydrate Pairing": This dietary strategy involves always consuming carbohydrates in conjunction with protein, healthy fats, or fiber. For instance, pairing an apple with peanut butter, or toast with nuts or an egg, helps to slow down glucose absorption, leading to more stable blood sugar levels and mitigating insulin spikes. This approach is foundational for both conditions.

2. Strategic Exercise Regimens: The timing, type, and quality of exercise are crucial. Regular physical activity, including a combination of cardiovascular exercise and strength training, can significantly improve insulin sensitivity and aid in weight management. High-intensity interval training (HIIT) has shown particular promise in improving metabolic markers. For PMOS, exercise can also help manage stress and improve mood.

3. Stress Reduction Techniques: Chronic stress elevates cortisol levels, which can disrupt hormonal balance and exacerbate insulin resistance. Implementing stress-management techniques such as mindfulness, meditation, yoga, or engaging in hobbies can have a profound positive impact on both PMOS and diabetes management.

Broader Implications and Future Outlook

The rebranding of PCOS to PMOS signifies a critical step forward in women’s health, fostering a more accurate understanding of a complex endocrine disorder. By highlighting the metabolic and polyendocrine nature of the syndrome, the medical community and patients alike can work towards more effective diagnosis, treatment, and long-term management. This shift is expected to drive further research into the intricate mechanisms of PMOS and its comorbidities, potentially leading to novel therapeutic interventions.

The increased awareness generated by this name change will undoubtedly empower more women to seek diagnosis and appropriate care. As Dr. Lynsey Johnson, DNP, APRN, FNP-C, an expert in PMOS and founder of PCOS Sisters Telehealth Clinic & Wellness Center, notes, "Asking your provider to investigate PMOS/PCOS is not adding unnecessary complications—it is simply unlocking the right vocabulary and tools to make sure your treatment plan works perfectly for your entire body." This proactive approach, coupled with a greater emphasis on integrated care and lifestyle modifications, offers a promising path towards better health outcomes for millions of women worldwide.

The collaborative effort behind this rebranding underscores a growing commitment to patient-centered care and the recognition that hormonal and metabolic health are inextricably linked. The transition to Polyendocrine Metabolic Ovarian Syndrome (PMOS) is more than a name change; it is a testament to evolving medical knowledge and a renewed dedication to improving the lives of women affected by this pervasive condition.

About the Author:
Dr. Lynsey Johnson, DNP, APRN, FNP-C, is an internationally recognized expert, innovator, speaker, and business leader in the field of PMOS/PCOS. She founded PCOS Sisters Telehealth Clinic & Wellness Center, a multi-state, evidence-based telehealth practice dedicated to supporting women with Polyendocrine Metabolic Ovarian Syndrome (PMOS/PCOS). Serving over 12 states across the USA, the clinic provides comprehensive PMOS diagnosis and treatment. Dr. Johnson also holds an Adjunct Instructor position and collaborates on research initiatives with Emory University’s Nell Hodgson Woodruff School of Nursing.